Cargando…
Monocyte to High-Density lipoprotein and Apolipoprotein A1 Ratios: Novel Indicators for Metabolic Syndrome in Chinese Newly Diagnosed Type 2 Diabetes
OBJECTIVE: Increasing evidence highlighted that chronic inflammation involved in the development of metabolic syndrome (MetS) and Type 2 diabetes mellitus (T2DM). This prospective study was aimed to assess the association between MetS and novel pro-inflammatory indicators like monocyte–to–high-densi...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330493/ https://www.ncbi.nlm.nih.gov/pubmed/35909551 http://dx.doi.org/10.3389/fendo.2022.935776 |
_version_ | 1784758174823219200 |
---|---|
author | Wang, Wei Chen, Zhe Yuan Guo, Xiu Li Tu, Mei |
author_facet | Wang, Wei Chen, Zhe Yuan Guo, Xiu Li Tu, Mei |
author_sort | Wang, Wei |
collection | PubMed |
description | OBJECTIVE: Increasing evidence highlighted that chronic inflammation involved in the development of metabolic syndrome (MetS) and Type 2 diabetes mellitus (T2DM). This prospective study was aimed to assess the association between MetS and novel pro-inflammatory indicators like monocyte–to–high-density lipoprotein and monocyte–to–apolipoprotein A1 ratios (MHR and MAR) in Chinese newly diagnosed T2DM. METHOD: A total of 605 Chinese newly diagnosed T2DM with complete and available data were enrolled in this study. Demographic and anthropometric information were collected. Laboratory assessments were determined by standard methods. MetS was based on the Chinese Diabetes Society definition. Multiple binomial logistic regression model was used to estimate the independent variables of MHR and MAR for MetS. Receiver operating characteristic (ROC) curve was conducted to assess the optimal cutoff value of MHR and MAR in identifying MetS. RESULTS: Overall, the prevalence of MetS was 60.2%. The correlation analysis showed that MHR and MAR were closely correlated with metabolic risk factors like body mass index, waist circumference, triglycerides, high-density lipoprotein cholesterol, systolic blood pressure, diastolic blood pressure, uric acid, and insulin resistance. MHR and MAR were also significantly associated with higher odds of MetS after adjustment for other confounders, the odds ratios (ORs) (95%CI) were 1.50 (1.14–1.97) and 2.26(1.79–2.87) respectively. Furthermore, MHR and MAR were also seemed to have higher area under the curve (AUC) for MetS than ApoA1 and monocyte alone from the ROC curve analysis (P < 0.05). The AUCs of MHR and MAR identifying MetS were 0.804 (95% CI: 0.768–0.839) and 0.840 (95% CI: 0.806–0.873) respectively (P < 0.001). The optimal cutoff values of MHR and MAR were 3.57 × 10(8)/mmol (sensitivity: 76.1%, specificity: 73.4%) and 3.95 × 10(8)/g (sensitivity: 79.7%, specificity: 84.6%), respectively. CONCLUSIONS: MHR and MAR were significantly associated with MetS. These two novel pro-inflammatory indicators may be useful markers for MetS in Chinese newly diagnosed T2DM. |
format | Online Article Text |
id | pubmed-9330493 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-93304932022-07-29 Monocyte to High-Density lipoprotein and Apolipoprotein A1 Ratios: Novel Indicators for Metabolic Syndrome in Chinese Newly Diagnosed Type 2 Diabetes Wang, Wei Chen, Zhe Yuan Guo, Xiu Li Tu, Mei Front Endocrinol (Lausanne) Endocrinology OBJECTIVE: Increasing evidence highlighted that chronic inflammation involved in the development of metabolic syndrome (MetS) and Type 2 diabetes mellitus (T2DM). This prospective study was aimed to assess the association between MetS and novel pro-inflammatory indicators like monocyte–to–high-density lipoprotein and monocyte–to–apolipoprotein A1 ratios (MHR and MAR) in Chinese newly diagnosed T2DM. METHOD: A total of 605 Chinese newly diagnosed T2DM with complete and available data were enrolled in this study. Demographic and anthropometric information were collected. Laboratory assessments were determined by standard methods. MetS was based on the Chinese Diabetes Society definition. Multiple binomial logistic regression model was used to estimate the independent variables of MHR and MAR for MetS. Receiver operating characteristic (ROC) curve was conducted to assess the optimal cutoff value of MHR and MAR in identifying MetS. RESULTS: Overall, the prevalence of MetS was 60.2%. The correlation analysis showed that MHR and MAR were closely correlated with metabolic risk factors like body mass index, waist circumference, triglycerides, high-density lipoprotein cholesterol, systolic blood pressure, diastolic blood pressure, uric acid, and insulin resistance. MHR and MAR were also significantly associated with higher odds of MetS after adjustment for other confounders, the odds ratios (ORs) (95%CI) were 1.50 (1.14–1.97) and 2.26(1.79–2.87) respectively. Furthermore, MHR and MAR were also seemed to have higher area under the curve (AUC) for MetS than ApoA1 and monocyte alone from the ROC curve analysis (P < 0.05). The AUCs of MHR and MAR identifying MetS were 0.804 (95% CI: 0.768–0.839) and 0.840 (95% CI: 0.806–0.873) respectively (P < 0.001). The optimal cutoff values of MHR and MAR were 3.57 × 10(8)/mmol (sensitivity: 76.1%, specificity: 73.4%) and 3.95 × 10(8)/g (sensitivity: 79.7%, specificity: 84.6%), respectively. CONCLUSIONS: MHR and MAR were significantly associated with MetS. These two novel pro-inflammatory indicators may be useful markers for MetS in Chinese newly diagnosed T2DM. Frontiers Media S.A. 2022-07-14 /pmc/articles/PMC9330493/ /pubmed/35909551 http://dx.doi.org/10.3389/fendo.2022.935776 Text en Copyright © 2022 Wang, Chen, Guo and Tu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Endocrinology Wang, Wei Chen, Zhe Yuan Guo, Xiu Li Tu, Mei Monocyte to High-Density lipoprotein and Apolipoprotein A1 Ratios: Novel Indicators for Metabolic Syndrome in Chinese Newly Diagnosed Type 2 Diabetes |
title | Monocyte to High-Density lipoprotein and Apolipoprotein A1 Ratios: Novel Indicators for Metabolic Syndrome in Chinese Newly Diagnosed Type 2 Diabetes |
title_full | Monocyte to High-Density lipoprotein and Apolipoprotein A1 Ratios: Novel Indicators for Metabolic Syndrome in Chinese Newly Diagnosed Type 2 Diabetes |
title_fullStr | Monocyte to High-Density lipoprotein and Apolipoprotein A1 Ratios: Novel Indicators for Metabolic Syndrome in Chinese Newly Diagnosed Type 2 Diabetes |
title_full_unstemmed | Monocyte to High-Density lipoprotein and Apolipoprotein A1 Ratios: Novel Indicators for Metabolic Syndrome in Chinese Newly Diagnosed Type 2 Diabetes |
title_short | Monocyte to High-Density lipoprotein and Apolipoprotein A1 Ratios: Novel Indicators for Metabolic Syndrome in Chinese Newly Diagnosed Type 2 Diabetes |
title_sort | monocyte to high-density lipoprotein and apolipoprotein a1 ratios: novel indicators for metabolic syndrome in chinese newly diagnosed type 2 diabetes |
topic | Endocrinology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330493/ https://www.ncbi.nlm.nih.gov/pubmed/35909551 http://dx.doi.org/10.3389/fendo.2022.935776 |
work_keys_str_mv | AT wangwei monocytetohighdensitylipoproteinandapolipoproteina1ratiosnovelindicatorsformetabolicsyndromeinchinesenewlydiagnosedtype2diabetes AT chenzheyuan monocytetohighdensitylipoproteinandapolipoproteina1ratiosnovelindicatorsformetabolicsyndromeinchinesenewlydiagnosedtype2diabetes AT guoxiuli monocytetohighdensitylipoproteinandapolipoproteina1ratiosnovelindicatorsformetabolicsyndromeinchinesenewlydiagnosedtype2diabetes AT tumei monocytetohighdensitylipoproteinandapolipoproteina1ratiosnovelindicatorsformetabolicsyndromeinchinesenewlydiagnosedtype2diabetes |